구제역(FMD) 시장 규모, 점유율, 성장 분석 : 백신 유형별, 동물 유형별, 유통 경로별, 지역별 - 업계 예측(2026-2033년)

FMD Disease Market size was valued at USD 3.48 Billion in 2024 and is poised to grow from USD 3.79 Billion in 2025 to USD 7.43 Billion by 2033, growing at a CAGR of 8.8% during the forecast period (2026-2033).

Market insights into foot-and-mouth disease (FMD) reveal a significant increase in the demand for veterinary vaccines, largely driven by the growing consumption of animal products and an expanding livestock population. This trend is closely linked to the rise of livestock and zoonotic diseases, exacerbated by environmental changes and rapid globalization. Governments worldwide are prioritizing effective medical practices for both livestock and companion animals to mitigate the economic impacts of disease outbreaks on national GDPs. The absence of definitive cures and multiple infection pathways underscored the critical need for vaccination strategies. As animal product demands surge, investment in FMD prevention becomes essential for stakeholders. In contrast, regions with stringent animal health measures have successfully controlled FMD, reducing the immediate necessity for vaccines.

Top-down and bottom-up approaches were used to estimate and validate the size of the FMD Disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

FMD Disease Market Segments Analysis

Global FMD Disease Market is segmented by Vaccine Type, Animal Type, Distribution Channel and region. Based on Vaccine Type, the market is segmented into Conventional vaccines and Emergency vaccines. Based on Animal Type, the market is segmented into Cattle, Sheep & goat, Pig and Other animals. Based on Distribution Channel, the market is segmented into Veterinary hospitals & clinics, Government institutions, Retail pharmacies and Online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the FMD Disease Market

The increasing consumption of animal protein and dairy products serves as a significant catalyst for the FMD (Foot-and-Mouth Disease) market. As the global population continues to rise, so does the need for livestock, which makes it crucial to address the impacts of FMD, a disease that can result in substantial economic losses within the livestock sector. Ensuring the health of livestock is paramount to meeting this demand, as outbreaks of FMD can hinder production levels and disrupt supply chains. Consequently, the focus on disease prevention and management strategies becomes essential for maintaining livestock health and supporting the overall growth of the meat and dairy industries.

Restraints in the FMD Disease Market

The financial burden associated with vaccines and diagnostic tests for foot-and-mouth disease (FMD) poses a significant challenge for the market, especially in developing nations that boast substantial livestock herds. The expense involved in acquiring and administering these essential preventative measures can limit accessibility for farmers and livestock producers who may already be facing economic hardships. This situation is exacerbated by limited resources and funding in these regions, making it difficult for stakeholders to implement effective FMD control strategies. Consequently, these financial constraints can hinder efforts to manage and mitigate the spread of the disease, affecting overall livestock health and productivity.

Market Trends of the FMD Disease Market

The FMD disease market is witnessing a notable trend characterized by a rising demand for FMD vaccines, particularly in developing nations where livestock farming is a vital economic activity. This surge is largely driven by proactive government initiatives aimed at controlling and preventing foot-and-mouth disease outbreaks. As awareness of the disease's impact on livestock health and agricultural productivity grows, authorities are increasingly investing in vaccination programs to safeguard animal welfare and ensure food security. Additionally, the collaboration between public and private sectors in vaccine development and distribution is further bolstering market growth, reflecting a concerted effort to mitigate the economic repercussions of FMD.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global FMD Disease Market Size by Vaccine Type & CAGR (2026-2033)

• Market Overview
• Conventional vaccines
  • Aluminium hydroxide & saponin-based vaccines
  • Oil-based vaccines
• Emergency vaccines

Global FMD Disease Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Cattle
• Sheep & goat
• Pig
• Other animals

Global FMD Disease Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary hospitals & clinics
• Government institutions
• Retail pharmacies
• Online pharmacies

Global FMD Disease Market Size & CAGR (2026-2033)

• North America (Vaccine Type, Animal Type, Distribution Channel)
  • US
  • Canada
• Europe (Vaccine Type, Animal Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Vaccine Type, Animal Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Vaccine Type, Animal Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Vaccine Type, Animal Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogenesis Bago (Argentina)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FMD Center World Reference Laboratory (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TAD Pharma GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tiankang Bio (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ringpu Biology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CAVAC (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Korea Animal Health Products Association (Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CZ Veterinaria (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations